Cargando…
Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches
Immunotherapy is extensively investigated for almost all types of hematologic tumors, from preleukemic to relapse/refractory malignancies. Due to the emergence of technologies for target cell characterization, antibody design and manufacturing, as well as genome editing, immunotherapies including ge...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663624/ https://www.ncbi.nlm.nih.gov/pubmed/33121189 http://dx.doi.org/10.3390/ijms21218000 |